General MedicationsOPHTHALMICGeneric

POLYSPORIN

BACITRACIN ZINC; POLYMYXIN B SULFATE

Standard Dose

500 UNITS/GM;10,000 UNITS/GM **Federal Register determination that product was not discontinued or withdrawn for s or e reasons**

Max Dose

Refer to approved labeling

Primary Use

Marketing status: Discontinued

Summary

Approval overview POLYSPORIN is listed in Drugs@FDA under application 061229 (ANDA).

Marketing status: Discontinued Active ingredient BACITRACIN ZINC; POLYMYXIN B SULFATE Form and strength OINTMENT;OPHTHALMIC - 500 UNITS/GM;10,000 UNITS/GM **Federal Register determination that product was not discontinued or withdrawn for s or e reasons** Sponsor MONARCH PHARMS Submission history Latest submission status date: 2006-01-31 00:00:00.

Structured Monograph

Clinical summary

Approval overview POLYSPORIN is listed in Drugs@FDA under application 061229 (ANDA). Marketing status: Discontinued Active ingredient BACITRACIN ZINC; POLYMYXIN B SULFATE Form and strength OINTMENT;OPHTHALMIC - 500 UNITS/GM;10,000 UNITS/GM **Federal Register determination that product was not discontinued or withdrawn for s or e reasons** Sponsor MONARCH PHARMS Submission history Latest submission status date: 2006-01-31 00:00:00. Submission type: SUPPL.

Monitoring

• Marketing status: Discontinued

Interaction Notes

No interaction notes stored yet.